Skip to main navigation Skip to search Skip to main content

Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo

Research output: Contribution to journal › Article › peer-review

93   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science